Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
13 p, 780.6 KB Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis / Zabalza, Ana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tagliani, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cárdenas-Robledo, Simón (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esperalba, Juliana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernandez-Naval, Candela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Trocoli Campuzano, Jesus (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez Gallo, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Castillo, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bonastre, Mercè (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Resina Sallés, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Beltran, Jordina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez-Barranco, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; López-Maza, Samuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Melgarejo Otálora, Pedro José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Ortiz, Mariano (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pappolla, Agustin (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tur, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Río, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Espejo, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nos, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Information about humoral and cellular responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and antibody persistence in convalescent (COVID-19) patients with multiple sclerosis (PwMS) is scarce. [...]
2022 - 10.1212/NXI.0000000000001143
Neurology® neuroimmunology & neuroinflammation, Vol. 9 (february 2022)  
2.
9 p, 776.0 KB Multiple sclerosis management during the COVID-19 pandemic / Moss, Brandon P. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Mahajan, Kedar R. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Bermel, Robert (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Hellisz, Kelsey (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Hua, Le H. (Lou Ruvo Center for Brain Health, Cleveland Clinic) ; Hudec, Timothy (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Husak, Scott (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; McGinley, Marisa P. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Ontaneda, Daniel (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Wang, Zhini (Department of Quantitative Health Sciences, Cleveland Clinic) ; Weber, Malory (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Tagliani, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cárdenas-Robledo, Simón (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodríguez-Barranco, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Douglas, Morgan (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Ogbuokiri, Esther (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Aravidis, Berna (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Cohen, Jeffrey A. (Mellen Center for Multiple Sclerosis, Cleveland Clinic) ; Mowry, Ellen M. (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Fitzgerald, Kathryn C. (Division of Neuroimmunology and Neurological Infections, Johns Hopkins University) ; Universitat Autònoma de Barcelona
People with multiple sclerosis (MS) may be at higher risk for complications from the 2019 coronavirus (COVID-19) pandemic due to use of immunomodulatory disease modifying therapies (DMTs) and greater need for medical services. [...]
2020 - 10.1177/1352458520948231
Multiple sclerosis, August 2020  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.